Vilfuro 200 Capsule 15s

ABOUT VILFURO 200 CAPSULE 15S

Vilfuro 200 Capsule 15s is a brand name for the generic medicine combination of Fluticasone Furoate (200mcg) and Vilanterol (25mcg). This combination is primarily used to manage and treat chronic obstructive pulmonary disease (COPD) and asthma, which are conditions characterized by breathing difficulties due to airway inflammation and constriction. Fluticasone Furoate is a corticosteroid that reduces inflammation in the airways, while Vilanterol is a long-acting beta-agonist that helps in relaxing the muscles around the airways, making it easier to breathe.

Vilfuro 200 Capsule 15s is available in capsule form, designed for inhalation use. This medicine is produced by Lupin Ltd, a reputable pharmaceutical company known for its commitment to quality and innovation in healthcare. Lupin Ltd meets WHO Good Manufacturing Practice (GMP) certification criteria according to CDSCO, ensuring that Vilfuro 200 Capsule 15s is manufactured under stringent quality standards.

Alternatives to Vilfuro 200 Capsule 15s include other brands with the same composition, such as Breo Ellipta and Relvar Ellipta, which also contain Fluticasone Furoate and Vilanterol. These alternatives provide similar therapeutic benefits and are used in the management of respiratory conditions.

INTRODUCTION OF VILFURO 200 CAPSULE 15S

Vilfuro 200 Capsule 15s is a highly effective medication designed to provide relief for individuals suffering from chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). These conditions are characterized by persistent inflammation and narrowing of the airways, leading to symptoms such as wheezing, shortness of breath, chest tightness, and coughing. The combination of Fluticasone Furoate and Vilanterol in Vilfuro 200 Capsule 15s works synergistically to address these symptoms and improve overall lung function.

Fluticasone Furoate, a potent corticosteroid, plays a crucial role in reducing inflammation within the airways. By decreasing the inflammatory response, it helps to prevent the exacerbation of symptoms and reduces the frequency of asthma attacks. Vilanterol, on the other hand, is a long-acting beta-agonist that works by relaxing the smooth muscles surrounding the airways. This relaxation leads to the widening of the airways, allowing for easier airflow and improved breathing.

Vilfuro 200 Capsule 15s is administered via inhalation, ensuring that the medication is delivered directly to the lungs where it is needed most. This targeted delivery system enhances the effectiveness of the medication while minimizing systemic side effects. Patients using Vilfuro 200 Capsule 15s can expect a significant improvement in their respiratory symptoms, leading to a better quality of life and increased ability to engage in daily activities without the burden of breathing difficulties.

CONDITIONS TREATED BY VILFURO 200 CAPSULE 15S

Vilfuro 200 Capsule 15s is primarily used to manage and treat chronic obstructive pulmonary disease (COPD) and asthma. These are chronic respiratory conditions that cause breathing difficulties due to inflammation and narrowing of the airways. By reducing inflammation and relaxing airway muscles, Vilfuro 200 Capsule 15s helps alleviate symptoms such as wheezing, shortness of breath, and coughing, improving overall lung function and quality of life for patients.

MOLECULE NAME

Fluticasone Furoate (200mcg) + Vilanterol (25mcg)

HOW IT WORKS VILFURO 200 CAPSULE 15S

Vilfuro 200 Capsule 15s works by combining the anti-inflammatory properties of Fluticasone Furoate with the bronchodilatory effects of Vilanterol. Fluticasone Furoate reduces inflammation in the airways, preventing the exacerbation of symptoms and reducing the frequency of asthma attacks. Vilanterol, a long-acting beta-agonist, relaxes the smooth muscles around the airways, leading to their dilation and improved airflow. This combination results in easier breathing and relief from respiratory symptoms.

COMMON SIDE EFFECTS OF VILFURO 200 CAPSULE 15S

Common side effects of Vilfuro 200 Capsule 15s may include headache, throat irritation, hoarseness, and cough. Some patients may also experience dizziness, nausea, or a change in taste. It is important to consult a healthcare professional if any side effects persist or worsen.

HOW TO TAKE VILFURO 200 CAPSULE 15S

Vilfuro 200 Capsule 15s should be taken as directed by a healthcare professional. It is typically administered via inhalation using a suitable inhaler device. Patients should follow the instructions provided with the medication to ensure proper use and dosage. It is important to rinse the mouth after inhalation to prevent oral thrush.

PRECAUTIONS OF VILFURO 200 CAPSULE 15S

Before using Vilfuro 200 Capsule 15s, patients should inform their healthcare provider of any allergies, medical conditions, or other medications they are taking. This medication should be used with caution in patients with a history of heart disease, high blood pressure, or diabetes. It is not intended for the relief of acute asthma attacks. Pregnant or breastfeeding women should consult their doctor before use.

FOOD & DRUG INTERACTIONS OF VILFURO 200 CAPSULE 15S

Patients should avoid consuming grapefruit or grapefruit juice while using Vilfuro 200 Capsule 15s, as it may increase the risk of side effects. It is also important to inform the healthcare provider of all medications being taken, as certain drugs may interact with Vilfuro 200 Capsule 15s, affecting its efficacy or increasing the risk of adverse effects.

ALTERNATIVE BRANDS OF VILFURO 200 CAPSULE 15S

Alternative brands with the same composition as Vilfuro 200 Capsule 15s include Breo Ellipta and Relvar Ellipta. These alternatives provide similar therapeutic benefits and are used in the management of respiratory conditions such as asthma and COPD.

FACT MEDICINE OF VILFURO 200 CAPSULE 15S

Vilfuro 200 Capsule 15s is a combination medication used to manage chronic respiratory conditions like asthma and COPD. It combines Fluticasone Furoate, a corticosteroid, with Vilanterol, a long-acting beta-agonist, to reduce inflammation and relax airway muscles. This medication is administered via inhalation, ensuring targeted delivery to the lungs. Produced by Lupin Ltd, Vilfuro 200 Capsule 15s meets WHO GMP standards, ensuring high-quality manufacturing. Patients should follow their healthcare provider's instructions for use and be aware of potential side effects and interactions.